Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,862.20
+275.42(+0.57%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Provectus Biopharmaceuticals, Inc. (PXY.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR

Add to watchlist

0.0450

0.0000

(0.00%)

At close: 02:55PM CEST

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	75.62M
Enterprise value	78.37M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	106.82
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-17.41

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-52.13%
S&P500 52-week change ³	26.27%
52-week high ³	0.1030
52-week low ³	0.0450
50-day moving average ³	0.0450
200-day moving average ³	0.0498

Share statistics

Avg vol (3-month) ³	N/A
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	419.52M
Implied shares outstanding ⁶	1.28B
Float ⁸	385.53M
% held by insiders ¹	9.42%
% held by institutions ¹	0.05%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Sept 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-1,024.36%

Management effectiveness

Return on assets (ttm)	-99.09%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	601.44k
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	-77.90%
Gross profit (ttm)	-1.32M
EBITDA	-2.96M
Net income avi to common (ttm)	-3.17M
Diluted EPS (ttm)	-0.0100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	367.25k
Total cash per share (mrq)	0
Total debt (mrq)	3.16M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.17
Book value per share (mrq)	-0.02

Cash flow statement

Operating cash flow (ttm)	-2.77M
Levered free cash flow (ttm)	-1.5M